Concept, Strategies, and Feasibility of Noninvasive Insulin Delivery
Open Access
- 1 January 2004
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (1) , 239-246
- https://doi.org/10.2337/diacare.27.1.239
Abstract
OBJECTIVE—To comprehensively review the progress to date on the development of alternative routes for insulin delivery. RESEARCH DESIGN AND METHODS—Study data were collected through a Medline review. RESULTS—Proof of principle has been established for many routes of administration including dermal, nasal, oral, buccal, and pulmonary insulin delivery. CONCLUSIONS—Of all the approaches to date, pulmonary delivery appears to be most feasible. Ongoing phase III studies will ultimately determine safety, tolerability, and efficacy before approval for clinical use.Keywords
This publication has 54 references indexed in Scilit:
- When oral agents fail: practical barriers to starting insulinInternational Journal of Obesity, 2002
- Inhaled insulin: a novel route for insulin deliveryExpert Opinion on Investigational Drugs, 2002
- TechnosphereTM/Insulin - proof of concept study with a new insulin formulation for pulmonary deliveryExperimental and Clinical Endocrinology & Diabetes, 2002
- Insulin AdministrationDiabetes Care, 2002
- Inhaled insulin1Abbreviations: DM, diabetes mellitus; AIDs, acquired immune deficiency syndrome; SC, subcutaneous; DCCT, Diabetes Control and Complications Trial; IDDM, insulin-dependent diabetes mellitus; NIDDM, non-insulin-dependent diabetes mellitus; i.v., intravenous; DDPC, di-decanoyl-alpha-phosphatidylcholine; AUC, area under the curve; INH, inhaled; Cmax, maximum serum concentration; Cmin, minimum serum concentration; Tmax, time of maximum serum concentration; NS, not significant; HbA1c, hemoglobin A1c; OA, oral agent; SD, standard deviation; MDI, metered dose inhaler; DPI, dry powder inhaler; MMAD, mass median aerodynamic diameter; CMC, critical micelle concentration; SR, sustained release; PLGA, poly lactic acid-co-glycolic acid; GI, gastrointestinal, GSD, geometric standard deviation; TLC, total lung capacity; VC, vital capacity; SMK, smokers; MW, molecular weight; MP, melting point.1Advanced Drug Delivery Reviews, 1999
- Biologically erodable microspheres as potential oral drug delivery systemsNature, 1997
- Absorption Characteristics of Chemically Modified‐Insulin Derivatives with Various Fatty Acids in the Small and Large IntestineJournal of Pharmaceutical Sciences, 1995
- Parenteral absorption of insulin from the lung in diabetic childrenJournal of Paediatrics and Child Health, 1987
- Intranasal Aerosolized InsulinNew England Journal of Medicine, 1985
- Bioavailability of Glipizide and its Effect on Blood Glucose and Insulin Levels in Patients with Non-insulin-dependent DiabetesDiabetes Care, 1982